Objective: To evaluate clinical pharmacist-led pain-medication education in patients with cancer. Methods: A controlled study was conducted prospectively at six tertiary hospitals in China. In-patients with cancer were randomized to receive conventional treatment plus medication education or no education (controls). Education consisted of access to information booklets and eight 30-min face-to-face counselling sessions given by clinical pharmacists over 4 weeks. Patients completed pain-and analgesic-knowledge assessments and a Brief Pain Inventory, pre-and poststudy.
Introduction
Pain is a common and perplexing symptom associated with many disorders. Large studies have documented that >75% of patients with advanced or terminal cancer experience pain and it has been reported that >50% of cancer patients do not receive effective pain relief. [1] [2] [3] Uncontrolled pain is therefore still an important problem among cancer patients in China. [1] [2] [3] There are three potential explanations for insufficient control of cancer pain. First, many healthcare professionals lack knowledge regarding analgesics and are not qualified to provide an adequate assessment of cancer pain; secondly, use of opioid analgesics is strictly limited in some countries; thirdly, patients often have prejudices against opioid analgesics, unnecessarily fearing addiction. In addition, traditional oriental culture encourages patients, especially men, to tolerate pain. Together these factors are responsible for inadequate cancer pain control in many patients. [4] [5] [6] [7] It is important that efforts are made to improve cancer pain control. Indeed, the Health Ministry of China issued a regulation in 2011 that Cancer Pain Standardization Treatment Units must be established in every teaching hospital in China. 8 According to this regulation, clinical pharmacists are required to provide a professional pain medication guide and to help patients effectively control cancer pain. Since there has been little opportunity for young Chinese clinical pharmacists to manage cancer pain, it is a challenge for them to now provide this service. The aim of the present study was to conduct a prospective, multicentre, randomized, controlled trial to assess the impact of education on analgesic medication, as provided by clinical pharmacists, in patients with cancer pain hospitalized at tertiary hospitals in Guangzhou, China.
Patients and methods

Study population
In-patients were recruited from six tertiary hospitals in Guangzhou, China between October 2011 and May 2012. Eligible patients: (i) were aged 18-70 years; (ii) were diagnosed with cancer by cytological, imaging and pathology tests; (iii) had cancer-related pain; (iv) had a performance status score of less than four; (v) had a life expectancy of >3 months; (vi) were able to communicate verbally. Patients were excluded from study participation if they had a major psychiatric disease or any other serious illness, including AIDS.
The study protocol was approved by the Ethics Committee of Zhujiang Hospital, Guangzhou, China, and all patients provided written informed consent after the study was fully explained to them.
Study design and process
This was a prospective, 4-week, multicentre, randomized controlled study. Eligible patients were randomized at study entry, using the RAND function in Excel, to one of two study groups: control or education. The control group received only conventional cancer pain control. Patients in the education group received conventional cancer pain control together with three information booklets: an Opioid and Analgesic Guide and a Cancer and Pain Guide (both written by the Chinese Anti-cancer Association Cancer Rehabilitation and Palliative Care Professional Committee), and Cancer Patients Medication Knowledge Guide (written by Y.W. and F.X.). The booklets provided patients with the following information: (i) definition and causes of cancer pain; (ii) pain assessment; (iii) communication with healthcare professionals regarding pain; (iv) cancer pain control; (v) opioid dose conversion; (vi) pain medication guide.
Patients were asked to read the booklets. Pharmacists were available to answer any questions and discuss any related issues. Each patient was then given eight face-toface education and counselling sessions, each lasting for $30 min over the course of 4 weeks. Clinical pharmacists made contact with patients in the education group every day, during the course of the study. At each round of contact they reviewed cancer control outcomes for each patient and made new recommendations to attending physicians, based on the patient's response, in order to provide individualized pain control. Patients were encouraged to keep in touch with the clinical pharmacist through various communication tools (including short messages and mobile phone contact). They were also encouraged to request a consultation for any pain control issue at any time.
Before the study start, clinical pharmacists received standardized training in order to achieve consistency in methods of investigation and patient education. Two pharmacists participated in the study at each centre: one was assigned to help patients complete study questionnaires; the other was responsible for patient education.
Study instruments
Study instruments consisted of a demographic and clinical characteristics form, a pain-related knowledge assessment and the Brief Pain Inventory (BPI), as discussed below. Pain-related knowledge assessments and BPI were completed at study entry and after 4 weeks.
The demographic and clinical characteristics form was used to collect basic patient information including: age, sex, education level, profession, work status and extent of disease. General patient condition was assessed by ZUBROD-ECOG-WHO Performance Status scores: 9 these scores range between 0 and 5, with 0 denoting perfect health and 5 death. The pain knowledge questionnaire consisted of six items as presented in Table 1 , and the analgesic knowledge questionnaire consisted of five items as shown in Table 2 . Both questionnaires were designed by all authors. The pain knowledge questionnaire generates a score ranging between one and eight, whereas the analgesic knowledge questionnaire generates a score ranging between four and 13. The total pain-related knowledge score represents the combined scores of the pain and analgesic questionnaires and generates an overall score ranging between five and 21, with five indicating very poor painrelated knowledge and 21 indicating excellent pain-related knowledge. The D-value was the change in total pain-related knowledge score between pre-and post-study. Patients were required to answer the questionnaire independently but were permitted to obtain help from the pharmacist if they were unable to complete it due to visual or reading problems.
The BPI was used to measure pain intensity and pain interference on daily life. The reliability and construct validity of the BPI has been confirmed in many studies. According to National Comprehensive Cancer Network Õ Clinical Practice Guidelines. [10] [11] [12] pain intensity was classified into five items: worst pain intensity in past week, usual pain intensity in past week, current pain intensity, pain intensity at rest, and pain intensity with movement. The score of each item ranged between 0 for no pain and 10 for worst pain imaginable. Pain interference on daily life was classified into seven items: daily activities; mood; walking Table 1 . Pain-knowledge questionnaire and scoring criteria administered to in-patients with cancer enrolled in a randomized controlled trial assessing the impact of pharmacist-led medication education.
Question
Answer Score, points 
Statistical analyses
Power analysis suggested that two sample sizes of 100 would provide 0.80 power to detect an effect size of 0.4 standard deviations, with a two-sided type-I (a) error rate of 0.05 and a 25% allowance for incomplete data. Data were collected before study start and after 4 weeks, inputted with double-check (Y.W. and F.X.) and analysed with SPSS Õ statistical software, version 13.0 (SPSS Inc., Chicago, IL, USA). Independent Student's t-test and the 2 -test were used to analyse any differences between the control group and the education group. Paired Student's t-test was used to analyse any differences before and after study within each group. Mann-Whitney U-test and Kruskal-Wallis H-test were used to compare within and between group differences in the change in total pain-related knowledge score (D-value), according to patient demographics and clinical characteristics. Analysis of covariance was used to compare post-study data between the two groups. A P-value of <0.05 (two-sided) was considered to be statistically significant.
Results
A total of 256 cancer pain in-patients were recruited into the study. Among them, 13 participants (eight in the control group and five in the education group) dropped out during the follow-up period because of death or advancing illness. Six patients in the control group withdrew from the study for other reasons. A total of 237 patients (114 in the control group and 123 in the education group) completed the whole investigation. The mean age of patients was 51.3 years (range 23-70 years). In both groups, >50% of patients were using (or had used) analgesics and $80% of patients overall experienced metastatic cancer. There were no significant differences with respect to any of the demographic and clinical characteristics between the two study groups (Table 3) .
There was no significant difference in pre-study total pain-related knowledge scores between the two groups ( Table 4) . At the end of study, patients' knowledge regarding cancer pain and pain control with analgesics was significantly increased in both the control and education groups (P < 0.05, Table 4 ). There was a significant difference in post-study total scores (pain and analgesic-knowledge scores combined) between the two groups (P < 0.05, Table 4 ). In the control group, the increase in total pain-related knowledge scores was significantly greater in patients who had never used analgesics compared with those who were using (or who had used) analgesics (P < 0.01, Table 5 ).
There were no significant differences between study groups with respect to five different pain intensity measures at baseline ( Table 6 ). All pain intensity scores significantly decreased in both the control and education groups on study completion, but reductions in the slope of pain intensity in the education group were significantly larger than those in the control group (P < 0.05, Table 6 ).
Baseline pain interference scores did not differ significantly between the two study groups. Within-group comparison of preand post-study scores indicated that all pain interference scores had significantly decreased (P < 0.05, Table 7 ). Post-study between-group comparison demonstrated that, with the exception of relationships with others, these six pain interference scores (daily activity, mood, walking ability, normal work, sleep and enjoyment of life were decreased significantly more in the education group (P < 0.05, Table 7 )
Discussion
In clinical practice, cancer pain education is usually led by physicians and nurses, and pharmacists have seldom or never been involved in this work. With the development of clinical pharmacy, the pharmacist has begun to conduct ward rounds to provide patients with direct pharmaceutical care and rational education on their medications. In practice, however, medication education is challenging for pharmacists to conduct. The present study demonstrated that clinical pharmacists could effectively enhance patient knowledge regarding cancer pain and analgesia by means of verbal and written modalities. These findings are consistent with other published studies. 13, 14 In the present study, there was a significant increase in post-study total pain-related knowledge scores in patients who received pharmacist-led education on medication compared with controls who received no guidance. The results also demonstrated that, in the control group, increases in the total pain-related knowledge score were greater in analgesic-naı¨ve patients compared with those who were using (or had used) analgesics. There are two possible explanations for the knowledge gain in the control group: first, although these patients did not receive education regarding their pain medication, they still obtained pain-related information through physicians and nurses or through package inserts; secondly, the control and education groups shared the same wards and it is possible that patients discussed their medication with one another, regardless of study-group assignment. Data from the present study also showed that pain intensity was statistically significantly reduced in the education group compared with the control group: a finding that is consistent with other research reports and meta-analyses. [15] [16] [17] [18] [19] [20] Some studies, however, report that education only significantly decreases worst pain intensity; 21, 22 others have found that there were significant reductions in average pain intensity and current pain intensity. 5 In the present study, pain intensity was also significantly decreased in the control group, since these patients still received effective pain management even without pharmacist education.
Pain interference significantly decreased from baseline in both groups in the present study since all pain patients received Within-group comparison (pre-versus post-study scores), paired Student's t-test. b Between-group comparison (control versus education group, post-study), analysis of covariance. There were no statistically significant differences between groups with respect to pre-study scores P ! 0.05 (independent Student's t-test). standardized treatment from their physicians, which relieved their pain to a certain extent. Post-study, all pain interference scores, with the exception of relationships with others, were significantly lower in the education group compared with the control group. It has been reported that there is a correlation between worst pain intensity and pain interference scores, since worst pain intensity impacts greatly on daily activities. 16, 23 The finding in the present study that there was no between-group difference in relationships with others post-study is, perhaps, because improvement of social Between-group comparison (control versus education group post-study), analysis of covariance. d No statistically significant difference (P ! 0.05) between groups post-study, with respect to relationships with others. No statistically significant differences between groups with respect to pre-study scores P ! 0.05 (independent Student's ttest). Classified according to National Comprehensive Cancer Network Õ Clinical Practice Guidelines; the score of each item ranged between 0, no pain and 10, worst pain imaginable. 10-12 b Within-group comparison (pre-versus post-study scores), paired Student's t-test.
c Between-group comparison (control versus education group post-study), analysis of covariance.
No statistically significant differences between groups with respect to pre-study scores P ! 0.05 (independent Student's t-test).
